41 completed, 10 unknown, 6 recruiting, 6 terminated. 74 Phase 3, 21 Phase 2.
Follow Colonic Diseases, Functional: new trials by email Literature Review of Colonic Diseases, Functional trials Research Report on Colonic Diseases, Functional
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders Rifaximin (drug), Placebo - Bloating, Rifaximin | Phase 3 | Not yet recruiting | Mahidol University | 78 | 2026-12-01 | 2026-10-27 |
| Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome Saccharomyces Boulardii 250 MG, Placebo 250 mg - IBS (Irritable Bowel Syndrome), IBS-D (Diarrhea-predominant) | Phase 3 | Recruiting | Biocodex | 406 | 2025-10-22 | 2025-11-18 |
| Study of Fecal Microbiota Transplantation (FMT) in Severe IBS Patients Administration of fecal microbiota transplantation ( FMT capsules), Administration of the sham (PLACEBO) - Irritable Bowel Syndrome | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 150 | 2025-07-01 | 2025-06-27 |
| Effects of Standardized Boswellia Carterii Extract on Irritable Bowel Syndrome Patients Boswellia carterii Extract, Educationntal program for IBS patie - Irritable Bowel Syndrome | Phase 2 / Phase 3 | Completed | Mansoura University | 60 | 2025-01-01 | 2026-05-08 |
| Ebastine Versus Mebeverine in IBS Patients Ebastine, Duspatalin - IBS - Irritable Bowel Syndrome, IBS | Phase 3 | Active not recruiting | Guy Boeckxstaens | 200 | 2023-03-30 | 2026-09-11 |
| Home Transcutaneous Electrical Acustimulation (TEA) TEA, Lexapro - Irritable Bowel Syndrome With Constipation | Phase 2 / Phase 3 | Recruiting | University of Michigan | 160 | 2022-11-02 | 2026-09-17 |
| Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study Small intestinal release peppermint oil, Peppermint sweets, Placebo - Irritable Bowel Syndrome, Functional Abdominal Pain Syndrome | Phase 3 | Completed | St. Antonius Hospital | 228 | 2022-05-12 | 2025-05-30 |
| Neurocognitive Effects of FMT in MDD Patients With and Without IBS Fecal Microbiota Transplantation - Major Depressive Disorder, Irritable Bowel Syndrome | Phase 2 / Phase 3 | Active not recruiting | Valerie Taylor | 133 | 2022-04-06 | 2026-03-19 |
| Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency synthetic human secretin - Abdominal Pain, Irritable Bowel Syndrome | Phase 3 | Terminated | Orlando Health, Inc. | 27 | 2022-01-28 | 2024-04-03 |
| Efficacy of a Low FODMAP Diet in the Absence of Lactose Malabsorption in Moderate to Severe ROME IV IBS. FODMAP diet - Irritable Bowel Syndrome | Phase 3 | Recruiting | Universitair Ziekenhuis Brussel | 60 | 2021-11-02 | 2025-12-18 |
| Predictive Value of Hydrogen/Methane Lactose Breath Testing on the Therapeutic Effect of Lactose-free Diet in Moderate to Severe ROME IV IBS. low fat diet - Irritable Bowel Syndrome, Lactose Intolerant | Phase 3 | Recruiting | Universitair Ziekenhuis Brussel | 90 | 2021-10-22 | 2025-12-18 |
| A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D) 25mg Eluxadoline, 100mg Eluxadoline - Irritable Bowel Syndrome | Phase 3 | Enrolling by invitation | AbbVie | 124 | 2021-08-13 | 2025-07-17 |
| Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome Fecal microbiota transplantation (FMT) - Irritable Bowel Syndrome | Phase 3 | Active not recruiting | University Hospital of North Norway | 450 | 2021-05-05 | 2024-02-26 |
| The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome Prucalopride 2mg - Irritable Bowel Syndrome | Phase 2 / Phase 3 | Unknown | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 160 | 2021-03-10 | 2021-10-22 |
| Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction Human Milk Oligosaccharides (HMO), Placebo - Spinal Cord Injuries, Neurogenic Bowel | Phase 3 | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 30 | 2021-01-27 | 2023-12-13 |
| Neostigmine and Glycopyrrolate by Iontophoresis Combination of Neostigmine and Glycopyrrolate, I-Box by Dynatronics - Spinal Cord Injuries, Constipation | Phase 3 | Active not recruiting | James J. Peters Veterans Affairs Medical Center | 6 | 2020-11-06 | 2024-04-08 |
| Frequency of Sleep Abnormalities in Patients With Irritable Bowel Syndrome and Effect of Pharmacological Intervention Melatonin 3 mg, Placebo - Irritable Bowel Syndrome | Phase 3 | Unknown | Sanjay Gandhi Postgraduate Institute of Medical Sciences | 194 | 2020-02-01 | 2020-03-16 |
| Antihistamines in the Treatment of Irritable Bowel Syndrome With Diarrhea Antihistamine, Placebo - Irritable Bowel Syndrome, Dermatographism | Phase 3 | Withdrawn | University of Cincinnati | 2020-02-01 | 2026-09-04 | |
| Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome pentoxyifylline, Mebeverine, ethosuximide - IBS - Irritable Bowel Syndrome | Phase 3 | Recruiting | Tanta University | 60 | 2019-11-01 | 2020-01-03 |
| Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome JCM-16021, Placebo - Irritable Bowel Syndrome | Phase 2 / Phase 3 | Unknown | ZhaoXiang Bian | 392 | 2018-11-08 | 2020-08-19 |
Showing 20 of 74. Sign in to see all of them.
Irritable Bowel Syndrome (71) · Constipation (9) · Diarrhea (9) · Abdominal Pain (8) · Intestinal Diseases (4) · Gastrointestinal Diseases (3) · Colonic Pseudo-Obstruction (2) · Fibromyalgia (2) · Neurogenic Bowel (2) · Spinal Cord Injuries (2) · Anxiety Disorders (1) · Borderline Personality Disorder (1) · Burning Mouth Syndrome (1) · Chronic Pain (1)
Colonic Diseases (73) · Digestive System Diseases (73) · Gastrointestinal Diseases (71) · Intestinal Diseases (70) · Pathological Conditions, Signs and Symptoms (25) · Signs and Symptoms (24) · Signs and Symptoms, Digestive (21) · Neurologic Manifestations (10) · Pain (10) · Nervous System Diseases (4) · Central Nervous System Diseases (3) · Mental Disorders (3) · Behavior (2) · Behavioral Symptoms (2)
Fecal Microbiota Transplantation (6) · Sugars (6) · Mesalamine (3) · Rifaximin (3) · eluxadoline (3) · ibodutant (3) · Acetylglucosamine (2) · Probiotics (2) · alosetron (2) · mebeverine (2) · 6-methylbenzo(b)thiophene-2-carboxylic acid (1-(2-phenyl-((1-(tetrahydropyran-4-ylmethyl)piperidin-4-ylmethyl)carbamoyl)ethylcarbamoyl)cyclophenyl)amide (1) · Anti-Bacterial Agents (1) · Antidepressive Agents (1) · Cetirizine (1) · Control Groups (1)
Menarini Group (3) · Astellas Pharma Inc (2) · Furiex Pharmaceuticals, Inc (2) · GlaxoSmithKline (2) · SOFAR S.p.A. (2) · Third Military Medical University (2) · Universitair Ziekenhuis Brussel (2) · University Hospital of North Norway (2) · University of Utah (2) · AbbVie (1) · Aleris-Hamlet Hospitaler København (1) · Alizyme (1) · American University of Beirut Medical Center (1) · Ashok Tuteja (1) · Assistance Publique - Hôpitaux de Paris (1)
United States (23) · United Kingdom (10) · Canada (8) · Germany (6) · Italy (6) · China (5) · France (5) · Belgium (4) · Czechia (4) · Norway (4) · Poland (4) · South Korea (4) · Australia (3) · Iran (3) · Netherlands (3)
Junkang Liu, Doctor (2) · Lin Chang, Professor (2) · A Masclee, Prof., PhD., MD. (1) · Ala' I. Sharara, MD (1) · Angela Bulawski (1) · Anthony Lembo (1) · Arine Vlieger, MD, PhD (1) · Ashok Tuteja (1) · Ashok Tuteja, MD, MPH (1) · Barbara Giovanni, Doctor (1) · Barbara Grube, MD (1)
PMID 26789872, PMID 28167156, PMID 11239312, PMID 11491192, PMID 11914441, PMID 17013448, PMID 18972769, PMID 20594245, PMID 22347818, PMID 23116208, PMID 23554827, PMID 24075889, PMID 24815298, PMID 25533646, PMID 25987795, PMID 28252569, PMID 29980607, PMID 30136447, PMID 30277094, PMID 30525951, PMID 31470006, PMID 31499231, PMID 31945816, PMID 32620184, PMID 34468079, PMID 34726293, PMID 34774080, PMID 35221706, PMID 36375174, PMID 36866724, PMID 40639240, PMID 41610933, PMID 42320473, PMID 42785338, PMID 6880820, PMID 9146781
2015 (1), 2019 (1), 5UH3NS115108-04 (1), R01DK049334 (1), R01NR004142 (1)